HealthLetter 200209
HealthLetter 200209
HealthLetter 200209
T
he Invisible Plague: Tbe Rise of
.Mental Illn ess from 1750
to the Present, combines a
Outra]le of the Month
Health Research Group Asks for Metabolife President to
meticulously researched history of the be Investigated.
sharp increases in the prevalence of He lied to the FDA. What are they going to do about it? ... .............. l2
serious mental illness with the chang-
ing societal reactions to this relatively
invisible plague. Interwoven through-
2 + September 2002
Update on the Illegal Promotion of
Gabapentin (Neurontin)
n the May 2002 issue of Wor.st This article is based on allegations approval. Instead, company officials
THE INVISIBLE PLAGUE, such things as changing exposure to causing society to move much more
frompage2 infectious agents (e.g., paralytic polio effectively to do something about it.
hospitals was in response to a per- increased as sanitation improved and Toward the end of the book, the
ceived need, that there was much young children were thus no longer authors quote from the Final Report
taxpayer resistance to building them, exposed to its innocuous early child- of the Joint Commission on Mental
and that families were usually reluc- hood form), toxins (e.g., PCB's affect Illness and Health's 1961 report:
tant to have their sick family mem- mental development in childhood),
bers hospitalized. or dietary changes. At this point in 1be way society handles it mental-
The authors believe that the most time, the authors admit that we can- ly ill has been the subject of scan-
likely explanation for the apparent not say for certain what might be dalized public attack many times.
increasing prevalence of insanity is causing increasing insanity. The Humane, healing care for the
simply that it has been truly increas- important thing is to recognize that mentally ill ... remains the great
ing. Existing data suggest that this insanity appears to be increasing unfinished business of the mental
increase has corresponded closely and, they argue persuasively, we health movement.. .A large propor-
with increasing urbanization. The must proceed with the necessary tion of mental patients in the pres-
increase does not appear to be relat- studies to ascertain why. ent, as in the past, are not treated
ed to social stress, since it appears to The book is an all-too-rare combi- in accordance with democratic,
have been unaffected by the World nation of medicine, history, sociolo- humanitarian, scientific and ther-
Wars or the Great Depression. Rather gy, anthropology and literature apeutic principles. We have sub-
the increase in insanity is most likely which will play an important role in stantially failed them on all
related to the biological antecedents making all the more visible this counts.
of the disease. These may include plague in our society and hopefully
4 +August 2002
could be used as the authors of these into public view. Because of the journal to accept a study for publica-
articles. In some cases, drafts of the detail of fabrications, pay-offs, tion. The FDA bases its drug
articles were completed even before manipulation, and their effect on approval decisions on its own review
an "author" agreed to place his or her gabapentin sales some widely held of the actual data submitted by a
name on the article. This even myths have been shattered. manufacturer, not on published jour-
occurred in connection with case his- First, and perhaps the most impor- nal articles. The agency has a staff of
tories that purported to describe the tant to the health and safety of highly trained statisticians who do
"author's" personal treatment of actu- patients, is the belief that doctors are their own analyses of the manufac-
al patients. The "authors" were paid not fooled or influenced by drug turer's data, thus ensuring that
an honorarium of $1,000 to lend their company promotional ploys such as approval decisions are based on
names to these articles, and also were gifts to attend medical meetings or valid data. Also, the agency has
able to claim publication credit on expensive meals. The evidence pre- authority to inspect clinical sites in
their professional resumes. sented in the court documents unam- order to keep investigators honest.
biguously shows that such schemes On the other hand, the editor of a
Speakers' Bureau work. Congress recognized 40 years peer reviewed medical journal must
Parke-Davis also formed a ago that a large proportion of physi- accept the veracity of a study submit-
Speakers' Bureau, another tactic to cians in everyday practice have nei- ted for publication. The editor will
make large and numerous payments ther the training nor the background send the study to several peer review-
to doctors who recommended to differentiate between a useful drug ers for their recommendations, but
gabapentin at teleconferences, din- and a harmful one. This is why these people have other things to do,
ner meetings, consultants meetings, Congress created a process by which and may spend only a few hours on
educational seminars, and other the FDA approves drugs based on their review. Peer reviewers also must
events. These speakers repeatedly validated science-to protect patients accept the veracity of the underlying
gave short presentations relating to from worthless or dangerous drugs. data presented in the study. The jour-
gabapentin for which they were paid But this says nothing about the nal editor has neither the authority
anywhere from $250 to $3,000. Some apparently substantial number of nor the resources to inspect clinical
speakers received tens of thousands doctors who accepted kickbacks or sites. This is a system that can be
of dollars annually in exchange for bribes to prescribe gabapentin for "gamed," as documented in the court
recommending to fellow physicians uses that had not been proven. The papers about Parke-Davis' gabapentin
that gabapentin be prescribed, par- memorable words of the inspector publication strategy.
ticularly for off-label uses. Speakers in the movie Casablanca-''I am The message for patients is that if
who most zealously advocated shocked-shocked!" come to mind. you have been prescribed a drug for
gabapentin were hired most fre- Second, the sacrosanct position of an off-label use, the evidence sup-
quently for speaking events, regard- peer-reviewed medical literature as a porting such a use may be good or it
less of the fact that many of these vehicle for scientific exchange has may be fabricated. The doctor pre-
events were billed as independent been seriously damaged. The manip- scribing the drug may have based the
medical education seminars where ulation of information about decision to use the drug on an
objective information was supposed gabapentin that Parke-Davis exer- expensive dinner, received a kick-
to be delivered. cised would astonish George Orwell. back or was bribed, or was simply
Circumstantial and some direct In defense of the many physicians fooled by a fabricated medical jour-
evidence over the years suggests that who try their best for patients by dili- nal article.
the behavior of Parke-Davis in the gently keeping up with the medical
off-label promotion of gabapentin is literature, there is no way for a doc- What You Can Do
not isolated, but rather an integral tor, scientist, or medical journal edi- If you or a family member receive
part of the pharmaceutical industry's tor to know if a study is a fabrication . gabapentin for a use not listed in the
marketing practices. However, in the There are major differences FDA approved professional product
Health Research Group's experience, between the way the FDA reviews labeling, discuss with your doctor
the gabapentin episode is the most clinical trials as part of the new drug the continued need for taking
complete and well documented case approval process and the process gabapentin.
of off-label promotion to ever come used by a peer reviewed medical
T his chart includes recalls from the Food and Drug Administration (FDA) Enforcement Report for drugs, dietary
supplements and medical devices, and Consumer Product Safety Commission (CPSC) recalls of consumer products.
Class I Recall
Name of Drug or Supplement; Clas.~ of Reca/~· Problem Lot #; Qmmtity and Distribution; Mtlmtjacturer
Comblvlr Tablets (lamivudine 150 mg/zidovudine 300 mg) 60 Lots 1ZP0848, 1ZP2346, 1ZP2347; 1.756 bottles distributed in
tablet bottles; Counterfeit: bottles labeled to contain Combivir Illinois, California, Indiana, New York, Tennessee, Pennsylvania,
tablets may contain Ziagen tablets Maryland and New Jersey; Alliance Wholesale Distributor, Richton
Park, Illinois
Nmue of Drug m· Supplement; Clas.~ of Recall; Pmblem Lot #; Quantity allfl Di.~t,·ilmtitm; Mmuifacturer
Acyclovir Tablets, 400 mg, Rx only, 100-count bottles; Class Ill; Lot 106091 A EXP 3/04; 11,483 bottles distributed nationwide; lvax
Tablet crumbling Pharmaceuticals, Inc., Miami, Florida
Col rex Compound Capsules, 100 capsule bottles, Rx only, Lot H000449A; 1,853 bottles distributed in New Jersey; Mikart, Inc.,
(Codeine Phosphate 16 mg, Acetaminophen 325 mg, Phenylephrine Atlanta, Georgia
Hydrochloride 10 mg, Chlorpheniramine Maleate 2 mg); Class Ill;
Low weight capsules
Desyrel Tablets (trazodone HCL), 100 mg, Rx only, packaged in Lots MLS08 and MKC09; Undetermined quantity distributed nation-
bottles of 100 and 1,000 tablets; Class Ill; Lack of content uniformi- wide; Bristol-Myers Squibb Co., Evansville, Indiana
ty-subpotent at 18 month stability
Esgic-Pius Capsules (Butalbital, Acetaminophen and Caffeine Lots D01 0201 A, D01 0202A, D01 0203B, J01 0602A, J01 0603B and
Capsules) 50 mg/500 mg/40 mg, 100 and 500 count bottles, Rx only; L010742A; 966/500 ct. bottles and 23,081/100 ct. bottles distributed
Class Ill; Low weight dosage units in Missouri; Mikart, Inc., Atlanta, Georgia
Luvox Tablets (Fiuvoxamine Maleate) (scored), 25 mg, 50 mg and Numerous lots; 1,503,114 units distributed nationwide; Solvay
100 mg 100 count bottles and unit dose packages of 100, Rx only; Pharmaceuticals, Inc., Marietta, Georgia
Class Ill; Inaccuracies in data submitted to the New Drug Application
by Solvay (stability)
6 + September 2002
MEDICAL DEVICES
Device recalls are classified in a manner similar to drugs, Class I, II or III, depending on the seriousness of the risk pre-
sented by leaving the device on the market. Contact the company for more information. You can also call the FDA's
Device Recall and Notification Office at (301) 443-4190. To report a problem with a medical device, call 1-800-FDA-
1088. The FDA web site is http.//wwwfda.gov.
Class I Recall
Nm11e of Device; Cltus of Reet1l~· Problem Lot #; Quautity ami Distributiou; Mtmufucturer
LTV Series Ventilators; Capacitor malfunction leading to quit LTV 1000, Catalog No. 10130. LTV 950, Cat. No. 10950. LTV 900,
with no alarm Cat. No. 10638. LTV 800, Cat. No. 11800; 3,348 distributed nation-
wide and internationally; Pulmonetic Systems, Inc., Colton,
California
Nm11e of Device; Class of Reetll~· Problem Lot #,· Qmmtity mul Di.~tributio11; Mmmfacturer
Contact Lens, Choice A.B. (aberation blocking) Daily wear soft Lots 0620, 1016, 1009, 0912,0924, 0925, 0926, 1025, 1004, 0926,
(hydrophilic); Class Ill; Polymer was undercured, lens may appear 1015,0829,0912,1023,0912,0921 , 0717,0916,10620,11025,
cloudy 10823, 10730; 781 units distributed nationwide; Specialty Ultravision,
St. Hubert, Quebec, Canada. Recalled by Ciba Vision Corp., Duluth,
Georgia
Disposable Syringe Kits; Class II; May exceed endotoxin specifica- Ct Tri Pak Sterile, catalog number CTP-200-FLS Lots 29764, 29765,
tion limits and 29766; 41 ,650 kits distributed nationwide and internationally;
Medrad, Inc., Indianola, Pennsylvania
CONSUMER PRODUCTS
Contact the Consumer Product Safety Commission (CPSC) for specific instructions or return the item to the place of
purchase for a refund. For additional information from the Consumer Product Safety Commission, call their hotline at
1-800-638-2772. The CPSC web site is www.cpsc.gov.
All-Terrain Vehicles (ATVs); Mounting-bracket weld on rear hub Warrior model, years 1997 and 1998; 14,000 sold nationwide from
can come loose, resulting in rear brake failure August 1996 through December 1997; Yamaha Motor Corporation,
U.S.A., Cypress, California (800) 88-YAMAHA www.yamaha-
motor.com
Bicycle Suspension Seat Posts; Cradle, which attaches to the Thudbuster, black and silver with serial numbers ranging between
bicycle seat, can break, posing the risk of falls and serious injury 10894 and 18710; 7,700 sold nationwide from November 2000
through June 2002; Cane Creek Cycling Components, Fletcher, North
Carolina (800) 234-2725 www.canecreek.com
Cigarette Lighters; Lighters do not have child-resistant mecha- Shape of Coca-Cola and Budweiser beverage containers; 1,800 sold
nisms, as required by federal law in Oregon and Washington from October 2001 through February
2002; Young's J.K. Inc., Portland, Oregon (503) 252-3022
Dive Computer Consoles; Pressure gauge can malfunction and U-Line, Smart PRO, Pro ULTRA, Sport PLUS; 1, 700 sold nationwide
display inaccurate pressure readings. Divers could fail to decompress from January through May 2002; Johnson Outdoors Inc., Racine,
properly during a dive Wisconsin (800) 382-2211 www.scubapro.com
Electrical Testing Meters; An incompatible grommet, located in Models CM-700 and CM-750; 650 sold nationwide during April2002;
battery compartment can cause meter to provide inaccurate voltage Greenlee Textron, Inc., Rockford, Illinois (800) 435-0786
and current readings, creating potential for electric shock or electrocu- www.greenlee.textron.com
tion
Extension Cords; Cords have undersized wires, presenting a shock Brown or white, 5-feet 3-inches long; 190,000 sold at discount stores
hazard nationwide from October 1998 through March 2002; STK International
Inc., Los Angeles, California (800) 536-7855
Gas Grills; Glass casing of thermometer displays attached to grills Series models 2000 and 3000; 1,800 sold in southeastern and south
can break or shatter central U.S. and on firm's web site from July 1999 through July 2002;
Flat Rock Grill Co., Powhatan, Virginia (888) 308-7399
www.flatrockgrill.com
Grass Bag Attachments; Rear-mounted grass bag does not seal Attachments for 19-inch electric walk-behind mowers; 5,000 sold
properly to the rear door of mower, allowing grass and other debris to nationwide from January through July 2002; MTD Products Inc.,
be thrown out at the top of the bag, creating a potential injury hazard Cleveland, Ohio (888) 848-6038
Juice Extractors or Juicers; Filter and lid can break apart and Model ACJ-250; 117,000 sold nationwide from March 1996 through
project metal and plastic into the air July 2002; Aroma Housewares Co., San Diego, California
(800) 276-6286
Mosquito Deletom Traps; Propane regulator can leak propane or Sold as part of the Portable and Back Home Systems, 24-inches high
allow an overflow posing a fire hazard with green or gray base; 136,000 sold nationwide from March through
July 2002; The Coleman Company Inc., Wichita, Kansas
(800) 257-5299 www.coleman.com
Pull-along Snails; Eyes on pull toy can detach, posing a choking Plan Toys, green, yellow and red wood, 10-inches long; 3,000 sold by
hazard internet retailers and mail order catalogs from June 2001through
June 2002; BRIO(r) Corp., Germantown, Wisconsin
(888) 274-6869
Riding Lawn Mowers; Excessive heat, vibrations and wear causes Hustler "FasTrak"; 1,500 sold nationwide from November 2001
the fuel line to droop over time and rub against the transmission fan, through May 2002; Excel Industries Inc., Hesston, Kansas
causing the fuel line to be cut, posing afire hazard (800) 395-4757 www.excelhustler.com
Smatter Spray Foam; If the pressurized can is left in a hot automo- Date codes 0492PT to 0952PT, sold in 3 varieties; 296,000 cans sold
bile, it can forcefully break apart and cause injury to a nearby con- nationwide from February through June 2002; Jakks Pacific Inc.,
sumer Malibu, California (800) 554-5516 www.jakkspacific.com
Sorter Toys; Plastic windows on the sorting blocks can break, caus- Sort & See wood box with shaped blocks; 880 sold nationwide from
ing beads to be released, presenting a choking hazard May through June 2002; Small World Toys, Culver City, California
(800) 421-4153
Toddler Puzzles; Dog puzzle included with both products and the Toddler Tote activity sets and Familiar Things puzzles; 121,000 sold
rubber handle on the box of the activity set can tear apart into small nationwide from January 1999 through July 2002; Lauri Inc., Phillips-
pieces and pose a choking hazard Avon, Maine (800) 451-0520
Toy Cars; Child can pull the horn from the steering wheel-small Model 8 Roadster, manufactured before January 2002; 59,000 sold
part poses a choking hazard nationwide from January 2001 through July 2002; Radio Flyer Inc.,
Chicago, Illinois (800) 708-9246 www.radioflyer.com
continued on page 9
8 + September 2002
Pressure On To Ban Ephedra
This story is reprinted from a tran- thought it was safe. But a growing screened by the FDA before they're
script of an August 13, 2002 broad- chorus of critics claims ephedra is put on the market. And the proof
cast on the CBS Evening News. not safe. required to force them off the market
Also called "Ma huang," ephedra is much higher than what's necessary
lso called "Ma huang, " is banned by the Olympics commit- to ban a dangerous drug.
c 0 N s u M E R p R 0 D u c T s COlli.
Vacation Station™ Children's Cooler/chairs; Folding mecha- Purple or green aluminum; 27,000 given to guests at participating
nism can pose acrushing, cutting or severing hazard to consumers' Hilton, Doubletree and Hilton Garden Inn hotels from May through
fingers June 2002; Hilton Hotels Corporation, Beverly Hills, California
(877) 221-2424 www.hilton.com/families
Vinyl Post Kits; Cracks can develop near the base of the posts Royal Colonial pre-built rail system; 1,250 sold in mid-Atlantic region
which can allow the railing to collapse, potentially injuring people on from February through April 2002; Royal Outdoor Products,
the deck Woodbridge, Ontario, Canada (877) 467-6925 www.royaloutdoor.com
T
his report su mmarizes West (n=one), Massachusetts (n=one), andinfection were reported from 37 states,
Nile virus (WNV) surveill anc District of Columbia (n=one). Nine New York City, and the District of
data re ported to the CDC by deaths have been reported from Columbia (Figure 1); 139 WNV infec-
ArboNET and by states and other Louisiana (n=seven) and Mississippitions in horses have been reported
jurisdictions as of August 14, 2002. from 15 states (Alabama, Florida,
(n=two). Among the 154 patients with
Georgia, Illinois, Kansas,
United States Kentucky, Louisiana, Min-
During the reporting FIGURE 1. Areas reporting West Nile virus (WNU) activity- nesota, Mississippi, Nebraska,
period of August 8--14, a United States, 2002* North Dakota, Ohio, South
total of 44 laboratory-posi- Dakota, Tennessee, and
tive human cases of WNV- Texas). During 2002, WNV
associated illness were seroconversions have been
reported from Mississippi reported in 62 sentinel chick-
(n=20), Louisiana (n=14), en flocks from Florida,
Alabama (n=three), Texas Nebraska, and Pennsylvania;
(n=two), Florida (n=one), 787 WNV-positive mosquito
Illinois (n=one), Indiana pools have been reported
(n=one), Massachusetts from 13 states (Alabama,
(n=one), and the District of f"-1 - Georgia, Illinois, Indiana,
Columbia (n=one). During
the same period, WNV
~""'t> Massachusetts, Mississippi,
Nebraska, New Jersey, Ohio,
infections were reported in Pennsylvania, South Dakota,
13} Recent human WNV Infection and animal WNV activity
382 dead crows, 310 other 1'5 Animal WNV activity only
Texas, and Virginia), New
dead birds, 52 horses, and York City, and the District of
• As ol August 14, 2002
362 mosquito pools. Columbia.
10 + September 2002
OUTRAGE, from page 12 access to these AERs." The DO] 2001.
documented each call received from underscored the urgency of the July The lawyer who approached you,
a consumer. 1 request by referring to the five year Jeff Wentworth, is, according to a May
In order to see if Ellis' allegation statute of limitations that exists 15, 2000 article in Time Magazine,
was supportable and as an important between the commission of an from a San Antonio law firm headed
source of data on the safety of these alleged crime and the filing of papers by some of President Bush's closest
products, the FDA subsequently concerning criminal prosecution. political associates and was hired by
asked the Department of justice "to "The statute of limitations for this Metabolife when Bush was governor
obtain the consumer adverse reac- crime is five years. Any such charges of Texas in order to influence the reg-
tion reports (AERs) documented by would have to be brought before ulation of ephedra by the Texas State
Metabolife." Previous efforts by the 4/17/03 [five years after the letter Health Department.
DO] to obtain these reports, filed by from Ellis to the FDA]." As you are aware, we petitioned
Metabolife under a gag order in a HHS to ban the manufacture and sale
California state court ephedra injury Previous Michael Ellis Criminal of all ephedra containing dietary
case, were thwarted because the Record supplements last September. By
judge refused the DO] request Metabolife President and co- now, there have been well over 100
because of the secrecy under which founder Michael Ellis was convicted deaths reported to the FDA in people
the documents were obtained during in 1990 on a drug-related charge using ephedra containing products
discovery from Metabolife in that involving the illegal manufacture and and, as described in our September
case. The DO] subsequently learned sale of methamphetamine which, 5, 2001, petition to ban these prod-
from an attorney, according to the interestingly, can be produced from ucts, there are more reports of death,
july 1 letter to Dan Troy, that in yet ephedra. He pleaded guilty to a stroke, arrhythmia, heart attacks,
another product liability case against felony charge. chest pain, seizures and hyperten-
Metabolife, the company had sion for ephedra than for all other
"received consumer reports of seri- Metabolife Political Influence dietary supplements combined. As
ous injuries related to the use of According to an article in The long as the FDA delays the inevitable
Metabolife before Ellis wrote his Washington Post (December 25, ban of these products, cases will
April 17, 1998 letter to FDA claiming 2000), Metabolife had, by October 1, continue to occur.
that Metabolife had received no such 2000, donated $683,000 to federal I urge you to free yourself from
reports." This is presumably the basis campaigns, ranking seventh among the influences that Metabolife and
for DO]'s allegation that Ellis may all pharmaceutical companies nation- other ephedra makers have had on
have made false statements to FDA wide. In Texas, the site of a battle the Texas Department of Health and
and "thereby, if done willfully, he between ephedra makers and the their continued massive lobbying in
may have committed a Federal state health department efforts to Washington against a ban of these
crime." more tightly regulate the dietary sup- most dangerous "food supplements."
The DO] letter goes on to state plement, Metabolife spent more than Any failure by your department to: a)
that "While we were unsuccessful in $4 million between 1998 and 2000 to agree to aggressively pursue a crimi-
getting access to the AERS in the lobby against state regulations. In nal investigation against Metabolife
California state court, Federal law is California, Metabolife ranked fourth President Michael Ellis for apparently
much more favorable to granting in state "soft money" contributions, lying to the government; b) to pur-
access to discovery materials when with $493,000 in 2000 and a $100,000 sue the acquisition of now-sealed
access to those materials will benefit donation to the campaign of Gov. court documents concerning serious
the public health and safety. Gaining Gray Davis, who subsequently adverse effects of Metabolife, many
access to these AERs will not only vetoed state legislation imposing likely not to have been reported to
give FDA a substantial amount of restrictions on ephedra use. the FDA because there is no require-
data with which to study the safety of More recently, the Los Angeles ment to do so; and c) to order a ban
ephedrine-based dietary supple- Times (September 6, 2001) reported on the production and distribution of
ments, it will also permit FDA and on the role of the current Bush ephedra products will ultimately
our office to assess the accuracy of Administration in suspending enforce- bring disgrace to you and your
Ellis' 4/17/98 letter to FDA and any ment of a Texas regulation to protect department.
potential criminal liability Ellis may athletes and other users of dietary
have for writing that letter. Asking supplements such as ephedra. This 1be evening this letter was
the Alabama court for access to the occurred, according to the L4 Times, sent, the Department of justice
Metabolife AERS will only require the after telephone calls to Austin, Texas, announced they are starting an
filing of a motion with the court. My from one of your senior aides after investigation into these charges.
office stands ready to handle making you were approached by a lawyer
such a request if FDA wishes to seek representing Metabolife in August
T
his letter strongly urges you to agree that the D O] be given the go- To support these contentions, Ellis
direct FDA Chief Counsel Dan ahead to try to obtain a large number stated in his letter that "Metabolife
Troy to agree that a criminal of adverse reaction reports of people has never received one notice from a
investigation of Metabolife be using Metabolife, o btained by plain- consumer that any serious adverse
opened, as requested in a July 1, tiffs' atto rneys during discovery from health event has occurred because of
2002, letter he was sent from Eugene the company, which are currently the ingestion of Metabolife 356 [a
M. Thirolf, Director, Office of under a gag order in a product liabil- best selling ephedra-containing diet
Co nsumer Litigation, U.S. Department ity case pending in Federal court in product]." Ellis also stated that "con-
of justice (DOJ). In that letter, the DO] Alabama. sequently, since there had been no
official states that Michael Ellis, the In a March 18, 1998, Federal serious adverse reports [AERs] of any
President of Metabolife, one of the Register Notice, the FDA asked for sort, there had been no such reports
natio n 's largest producers of comme nts conce rning the abuse of overuse or abuse of the product. "
ephedrine-based dietary supplements, potential, actual abuse, medical use- Ellis described Metabolife's monitor-
may have made false statements to fulness and trafficking of ephedrine . ing system, including how Metabolife
the FDA and "thereby, if done willful- In respo nse, Michael Ellis , President continued on page 11
NOI.ldiHOSBnS
SS31:100)f
12 + September 2002